These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24814431)

  • 1. Mortality risk score for Klebsiella pneumoniae bacteraemia.
    Chetcuti Zammit S; Azzopardi N; Sant J
    Eur J Intern Med; 2014 Jul; 25(6):571-6. PubMed ID: 24814431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
    Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
    J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
    Chang EK; Kao KL; Tsai MS; Yang CJ; Huang YT; Liu CY; Liao CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):684-91. PubMed ID: 26510516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
    Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
    J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients--characteristics of neutropenic and non-neutropenic patients.
    Lin YT; Liu CJ; Fung CP; Tzeng CH
    Scand J Infect Dis; 2011 Aug; 43(8):603-8. PubMed ID: 21539500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
    Hernández-Roca JJ; García-Vázquez E; Hernández A; Canteras M; Herrero JA; Cascales E; Mené-Fenor E; Gómez-Gómez J
    Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia.
    Meatherall BL; Gregson D; Ross T; Pitout JD; Laupland KB
    Am J Med; 2009 Sep; 122(9):866-73. PubMed ID: 19699383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for in-hospital mortality in patients with type 2 diabetes complicated by community-acquired Klebsiella pneumoniae bacteremia.
    Huang CH; Tsai JS; Chen IW; Hsu BR; Huang MJ; Huang YY
    J Formos Med Assoc; 2015 Oct; 114(10):916-22. PubMed ID: 26315482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong.
    Man MY; Shum HP; Chan YH; Chan KC; Yan WW; Lee RA; Lau SKP
    J Hosp Infect; 2017 Sep; 97(1):35-41. PubMed ID: 28602703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
    Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
    Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study.
    Liao CH; Lai CC; Hsu MS; Huang YT; Chu FY; Hsu HS; Hsueh PR
    Clin Microbiol Infect; 2009 Dec; 15(12):1119-25. PubMed ID: 19392886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia.
    Lee HC; Chuang YC; Yu WL; Lee NY; Chang CM; Ko NY; Wang LR; Ko WC
    J Intern Med; 2006 Jun; 259(6):606-14. PubMed ID: 16704562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
    Liu SW; Chang HJ; Chia JH; Kuo AJ; Wu TL; Lee MH
    J Microbiol Immunol Infect; 2012 Apr; 45(2):113-9. PubMed ID: 22154994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.